# A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors

> **NCT02813902** · PHASE1 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Keratosis, Actinic
- Keratosis
- Skin Neoplasms

## Interventions

- **DRUG:** Heliocare with Fernblock PLE technology
- **OTHER:** Sugar Pill

## Key facts

- **NCT ID:** NCT02813902
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-07
- **Primary completion:** 2020-05
- **Final completion:** 2020-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding.
- **Last updated:** 2019-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02813902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02813902, "A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02813902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*